[Study EXPO 2010: Overweight and Obesity in Childwood]

Diana L Martins1, Ana Isabel Branco, J Luís Fernandes

  • 1Departamento de Medicina Geral e Familiar, Unidade de Saúde Familiar, Nova Via, ACES Espinho/Gaia, Gaia, Portugal.

Insights

Childhood overweight and obesity are rising, with concerningly low quality in health records for diagnosis and treatment. Improvements are needed to address this growing public health issue effectively.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Informatics

Context:

  • Childhood overweight and obesity prevalence is increasing significantly.
  • This trend poses risks for severe co-morbidities in children.
  • Early detection and management are crucial, especially during health exams.

Purpose:

  • To assess the technical and scientific quality of health records related to childhood overweight and obesity.
  • To evaluate the registration of diagnoses, diagnostic tests, and therapeutic counseling.
  • To identify areas for improvement in managing pediatric weight issues.

Summary:

  • A retrospective study evaluated 118 children (ages 5-13) with overweight/obesity.
  • Quality of records for diagnosis, testing, and counseling was largely "Unsatisfactory," particularly in younger children.
  • Teenagers showed better, though still incomplete, results in some criteria.

Impact:

  • Highlights deficiencies in clinical documentation and management of pediatric obesity.
  • Underscores the need for enhanced clinical guidelines and professional training.
  • Informs targeted interventions to improve care quality for overweight and obese children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...